CY1105481T1 - Συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη αλωπεκιας - Google Patents

Συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη αλωπεκιας

Info

Publication number
CY1105481T1
CY1105481T1 CY20041101452T CY041101452T CY1105481T1 CY 1105481 T1 CY1105481 T1 CY 1105481T1 CY 20041101452 T CY20041101452 T CY 20041101452T CY 041101452 T CY041101452 T CY 041101452T CY 1105481 T1 CY1105481 T1 CY 1105481T1
Authority
CY
Cyprus
Prior art keywords
alopecia
scalp
compositions
methods
therapeutic treatment
Prior art date
Application number
CY20041101452T
Other languages
English (en)
Inventor
Morris A. Mann
Original Assignee
Regenerx Biopharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenerx Biopharmaceuticals Inc. filed Critical Regenerx Biopharmaceuticals Inc.
Publication of CY1105481T1 publication Critical patent/CY1105481T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)

Abstract

Αποκαλύπτονται συνθέσεις αναγεννήσεως κόμης που περιέχουν Τα1, Τβ4 ή συνδυασμό αυτών δια την θεραπευτική αγωγή αλωπεκίας επί του τριχωτού μέρους ενός ασθενούς που έχει ανάγκη αυτών. Οι μέθοδοι θεραπευτικής αγωγής περιλαμβάνουν (1) καθαρισμό του τριχωτού μέρους με παράγοντα καθαρισμού, (2) θεραπευτική αγωγή του καθορισθέντος τριχωτού μέρους με σύστημα διαλύσεως κεράτινης, (3) εφαρμογή τοπικού αναισθητικού (ενδεχομένως), (4) εφαρμογή όξινου διαλύματος αποφλοιώσεως, (5) εφαρμογή υπερδραστικού τύπου πήγμα (gel) ουρίας (ενδεχομένως) και (6) εφαρμογή συνθέσεως αναγεννήσεως κόμης.
CY20041101452T 1997-12-19 2004-12-08 Συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη αλωπεκιας CY1105481T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/994,347 US6030948A (en) 1997-12-19 1997-12-19 Hair regeneration compositions for treatment of alopecia and methods of application related thereto
PCT/US1998/026955 WO1999032072A1 (en) 1997-12-19 1998-12-18 Compositions and methods for treatment of alopecia

Publications (1)

Publication Number Publication Date
CY1105481T1 true CY1105481T1 (el) 2010-04-28

Family

ID=25540565

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20041101452T CY1105481T1 (el) 1997-12-19 2004-12-08 Συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη αλωπεκιας

Country Status (12)

Country Link
US (1) US6030948A (el)
EP (1) EP1039874B1 (el)
JP (3) JP2001526200A (el)
AT (1) ATE275379T1 (el)
AU (1) AU1928199A (el)
CA (1) CA2315395C (el)
CY (1) CY1105481T1 (el)
DE (1) DE69826149T2 (el)
DK (1) DK1039874T3 (el)
ES (1) ES2232977T3 (el)
PT (1) PT1039874E (el)
WO (1) WO1999032072A1 (el)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
US20070191275A1 (en) * 1998-07-30 2007-08-16 Regenerx Biopharmaceuticals, Inc. Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
US20040067227A1 (en) * 2001-11-02 2004-04-08 Goldstein Allan L. Inhibition or reversal of skin aging by actin-sequestering peptides
CA2338928A1 (en) * 1998-07-30 2000-02-10 Hynda K. Kleinman Thymosin .beta.4 promotes wound repair
US20060100156A1 (en) * 2004-10-01 2006-05-11 Regenerx Biopharmaceuticals, Inc. Cell nucleus-entering compositions
US20080096817A1 (en) * 1998-07-30 2008-04-24 Regenerx Biopharmaceuticals, Inc. METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6558656B2 (en) * 2000-04-20 2003-05-06 Morris Mann Oral and topical compositions and methods related thereto in the treatment of acne
FR2813190A1 (fr) * 2000-08-22 2002-03-01 Oreal Utilisation d'une sapogenine pour traiter les desordres lies a une suractivite de la 5-alpha reductase
US20070092450A1 (en) * 2000-10-16 2007-04-26 Mallinckrodt Inc. Tissue-specific exogenous optical agents
US20040180809A1 (en) * 2000-10-16 2004-09-16 Mallinckrodt Inc. Tissue-specific exogenous optical agents
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2003013245A1 (en) * 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US20030049283A1 (en) * 2001-08-31 2003-03-13 Vandell Victor E. Scalp desensitizing formulation
US7348352B2 (en) * 2001-10-23 2008-03-25 Bioresponse L.L.C. Diindolylmethane for the treatment of HPV infection
TWI353849B (en) * 2002-01-25 2011-12-11 Us Gov Health & Human Serv Methods and compositions for the promotion of hair
US20050027016A1 (en) * 2002-02-07 2005-02-03 Fahl Kathleen L Polyamine compounds and compositions for use in conjection with cancer therapy
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
KR100849916B1 (ko) * 2002-10-30 2008-08-04 아에스아테 아게 어플라이드 사이언스 앤드 테크놀로지 멜라토닌 일일 투여 유닛
US7622103B1 (en) 2003-03-27 2009-11-24 Cielo Jill M Hair and scalp toxin remover composition and method of its making
FR2855753B1 (fr) * 2003-06-03 2007-09-14 Dermo Cosmologie Lab De Composition a base de diosgenine applicable par voie topique
US20050084509A1 (en) * 2003-10-20 2005-04-21 Bernstein Eric F. Use of citric acid and low concentrations of alpha-hydroxy acids for superficial skin treatment
EP1706128B1 (en) * 2003-12-08 2010-07-21 CPEX Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060009430A1 (en) * 2004-07-01 2006-01-12 Kelly Gregory J Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
US8349304B1 (en) * 2005-07-28 2013-01-08 Kerri Lynn Tate Evaporative cooling composition
US20070048360A1 (en) * 2005-08-23 2007-03-01 R Carrara Dario N Pharmaceutical compositions with melting point depressant agents and method of making same
GB0518558D0 (en) * 2005-09-12 2005-10-19 Givaudan Sa Improvements in or related to organic compounds
JP2011504917A (ja) * 2007-11-30 2011-02-17 イムンディアグノスティック アクチェンゲゼルシャフト 抜け毛および若白髪の治療および予防のための組成物
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
EP2344198B1 (en) * 2008-09-27 2020-11-04 Jina Pharmaceuticals Inc. Lipid based pharmaceutical preparations for topical application
US20100120871A1 (en) * 2008-11-10 2010-05-13 Dawson Jr Thomas Larry Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
FR2953722B1 (fr) * 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
JP2013514261A (ja) * 2009-12-18 2013-04-25 ロレアル ケラチン繊維を処理する方法
US8580742B2 (en) * 2010-03-05 2013-11-12 N.V. Perricone Llc Topical glutathione formulations for menopausal skin
US8609604B2 (en) 2009-12-28 2013-12-17 N.V. Perricone Llc Methods of improving the appearance of aging skin
JP5588167B2 (ja) * 2009-12-28 2014-09-10 ライオン株式会社 育毛養毛剤、毛周期変換剤および育毛養毛組成物
US20110160144A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Formulations
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9700504B2 (en) * 2012-06-19 2017-07-11 Debraj Shome Composition and method for an intradermal hair growth solution
JP5283775B1 (ja) * 2012-09-07 2013-09-04 佐藤製薬株式会社 発毛促進剤
FR2997846B1 (fr) * 2012-11-09 2023-10-20 Oreal Composition comprenant un derive dicarbonyle et un acide, le procede de lissage des fibres keratiniques a partir de cette composition
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
ES2754353T3 (es) 2014-05-23 2020-04-17 Triple Hair Inc Composiciones para reducir la caída del cabello y/o aumentar la regeneración del cabello
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
ES2902842T3 (es) 2015-07-08 2022-03-30 Triple Hair Inc Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
DE102015111123A1 (de) * 2015-07-09 2017-01-12 Andreas Schulze Kosmetische Pflege von ergrautem Haar
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3334424B1 (en) * 2015-08-13 2020-10-14 River Town Therapeutics, Inc. At175, minoxidil and cyclosporin a for treating alopecia
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US9949939B2 (en) 2016-07-01 2018-04-24 Transdermal Biotechnology, Inc. Systems and methods for treating vitiligo
WO2019012353A1 (en) * 2017-07-11 2019-01-17 Shilpa Medicare Limited TOPICAL COMPOSITIONS OF DUTASTERIDE
DE102019131415A1 (de) * 2019-11-21 2021-05-27 Lukas Karrer Kosmetische Pflege von ergrautem Haar und Wiederrückführung von ergrautem Haar zur ursprünglichen Haarfarbe
CU24626B1 (es) * 2019-12-26 2022-11-07 Centro Nac De Biopreparados Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP3919044A1 (en) * 2020-06-04 2021-12-08 International Flavors & Fragrances Inc. Composition and method for improving fragrance intensity with isopropyl myristate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8307692A (pt) * 1983-03-01 1985-02-20 Rudolf Trensch Composicao de tratamento de cabelo e processo para o tratamento de cabelo
JPS62252711A (ja) * 1986-04-24 1987-11-04 Hideharu Tamaki 養毛剤
US5068315A (en) * 1990-04-12 1991-11-26 University Of Dundee Composition for the regulation of hair growth
DE19509354A1 (de) * 1994-12-08 1996-06-13 Klett Loch Lore M Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant

Also Published As

Publication number Publication date
PT1039874E (pt) 2005-02-28
EP1039874A1 (en) 2000-10-04
JP2001526200A (ja) 2001-12-18
WO1999032072A1 (en) 1999-07-01
DK1039874T3 (da) 2005-01-24
ES2232977T3 (es) 2005-06-01
ATE275379T1 (de) 2004-09-15
EP1039874B1 (en) 2004-09-08
CA2315395A1 (en) 1999-07-01
CA2315395C (en) 2008-03-18
JP2007302705A (ja) 2007-11-22
DE69826149D1 (de) 2004-10-14
DE69826149T2 (de) 2005-09-22
JP2010168407A (ja) 2010-08-05
AU1928199A (en) 1999-07-12
US6030948A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
CY1105481T1 (el) Συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη αλωπεκιας
FR2712286B1 (fr) Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
ATA281885A (de) Faerbemittel, sowie faerbeverfahren fuer keratinfasern und insbesondere fuer humanhaare
EP1021179A4 (en) METHOD FOR PROMOTING HAIR GROWTH AND DEVELOPING THE HAIR SYSTEM
TR200000694T2 (tr) Cilt sağlığını korumak veya geliştirmek için bir yöntem.
BR9303433A (pt) Composicao viscoelastica linear para a higiene ou cuidados pessoais,processo para a promocao da higiene e cuidados pessoais,processo para a fixacao dos cabelos,processo para a promocao da higiene e cuidados da pele,e,uso de um agente espessante polimerico
BR9610760A (pt) Composição cosmética ou dermatológica e processo n o-terapêutico de tratamento das matérias queratínicas
DE69812948D1 (de) Hautaufhellendes kosmetisches mittel
ECSP055712A (es) Combinación sinérgica de proteínas de seda
DK241588A (da) Topisk haarvaekstmiddel
BR9700517A (pt) Composição cosmética processo de tratamento cosmético de fibras queratínicas e utilização da composição cosmética
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
BR9501652A (pt) Usos de um antagonista de substancia P em uma composição cosmética processo de tratamento cosmético composição cosmética e uso da capsaicina
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
BR0005084B1 (pt) composições cosméticas, processo de tratamento das matérias queratìnicas e utilização de um co-polìmero siliconado.
BR0110758A (pt) Agente cosmético para cabelos, e, uso de agentes
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DE69500062D1 (de) Set, Verfahren, Mittel und Zusammensetzung zur Färbung von Keratinfasern
HUP9900511A2 (hu) Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
ES2103145T3 (es) Composicion para el tratamiento y la proteccion de los cabellos, pestañas y cejas a base de ceramidas y de polimeros de vinilpirrolidona.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATA276585A (de) Faerbemittel fuer keratinfasern, insbesondere fuer menschliche haare, und verfahren zum faerben von keratinfasern, insbesondere von menschlichen haaren
FR2717683B1 (fr) Composition capillaire à base de minoxidil.
DK115389D0 (da) Applikator til hudrensemiddel, hudplejemiddel og medicinsk indgnidningsmiddel